Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Indian shares mark 2-1/2 week closing low; anxiety around RBI, Fed

Mon, 16th Dec 2013 11:14

* BSE index falls 0.27 pct; NSE ends 0.22 pct lower * India's wholesale price inflation hits 14-month high * GlaxoSmithKline Pharma surges on open offer by parent * Overseas investors snap 10-day buying streak in Indianshares By Abhishek Vishnoi MUMBAI, Dec 16 (Reuters) - Indian shares fell for a fifthstraight session on Monday as investors pared positions inblue-chip stocks such as Reliance Industries ahead of theReserve Bank of India and the U.S. Federal Reserve's policymeetings later this week. India's wholesale price inflation hit a 14-month high inNovember, as food price surged, cementing expectations thecentral bank will raise interest rates for a third consecutivetime at its policy review on Wednesday. Traders say a rate hike, although factored in to an extent,could undermine the confidence of investors and Indian companiesas the economy remains in a fragile state with growthlanguishing below 5 percent. Foreign institutional investors sold Indian shares worth4.32 billion rupees ($69.49 million) on Friday, to snap their10-day buying streak, raising concerns ahead of the Fed'smeeting ending on Wednesday. The Fed is widely expected to start withdrawing its monetarystimulus by early next year. "Fears about the prospects of a hawkish stance by the RBIgovernor have increased in the background of recent gloomy CPIand WPI data," said Gaurang Shah, assistant vice president at Geojit BNP Paribas Financial Services Ltd. Anything above 25 bps rate hike could spook the markets inthe near term, Shah added. The benchmark BSE index fell 0.27 percent, or 56.06points, to 20,659.52, marking its lowest close since Nov. 28.The index is now 4 percent away from a record high of 21,483.74hit a week earlier. The broader NSE index ended lower 0.22 percent, or13.70 points, at 6,154.70, marking its biggest losing streaksince the seven days ending Nov. 13. Among blue-chip shares, Reliance Industries Ltd fell 2.3 percent, while Sun Pharmaceutical Industries Ltd ended lower 2.6 percent. Among rate-sensitive stocks, mortgage lender HousingDevelopment Finance Corporation Ltd fell 1 percent,while Mahindra and Mahindra Ltd ended 2.5 percentlower. Tata Chemicals Ltd fell 1.2 percent after the RBIplaced a cap on further foreign institutional investments in thecompany. Clariant Chemicals India Ltd fell 2.1 percentafter the company said it intends to acquire PlastichemixIndustries for 1.35 billion rupees. Steel shares fell after a measure of growth in China's vastfactory sector slowed to a three-month low in December asreduced output offset a pick-up in new orders. Tata Steel Ltd fell 1.5 percent, while JindalSteel and Power Ltd ended 3.2 percent lower. However, among stocks that gained, GlaxoSmithKlinePharmaceuticals Ltd surged 18.9 percent after parentGlaxoSmithKline Plc said it plans to spend over $1billion to buy up to 20.6 million shares to raise its stake inits Indian unit. For additional stocks on the move double click FACTORS TO WATCH * Euro zone activity data helps euro, but Fed holds * Oil above $109 as Libyan oil ports stay shut * Europe lifted by PMI data, China wobble hits Asia * Foreign institutional investor flows * For closing rates of Indian ADRs ASIA-PACIFIC STOCK MARKETS: Pan-Asia........ Japan....... S.Korea... S.E. Asia....... Hong Kong... Taiwan.... Australia/NZ.... India....... China..... OTHER MARKETS: Wall Street .... Gold ....... Currency.. Eurostocks..... Oil ........ JP bonds... ADR Report ..... LME metals. US bonds.. Stocks News US.. Stocks News Europe DIARIES & DATA: Indian Data Watch Asia earnings diary U.S. earnings diary European diary Indian diary Wall Street Week Ahead Eurostocks Week Ahead TOP NEWS: For top Asian company news, double click on: U.S. company news European company news Forex news Global Economy news Technology news Telecoms news Media news Banking news Politics/General Asia Macro data

More News
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.